Latest Stories
Why Elevance Health (ELV) Stock Is Trading Up Today
Shares of health insurance provider Elevance Health (NYSE:EVH) jumped 3% in the morning session after Wolfe Research upgraded the stock's rating to Outperform from Peerperform and set a price target of $425.
Why Is Neogen (NEOG) Stock Rocketing Higher Today
Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 27.6% in the morning session after the company reported fourth-quarter results that far surpassed Wall Street's expectations and raised its financial forecast for the full year.
Amentum (AMTM) Stock Is Up, What You Need To Know
Shares of government engineering solutions provider Amentum Holdings (NYSE:AMTM) jumped 2.4% in the morning session after the company received positive analyst commentary, a credit rating upgrade, and a new contract award, pushed the stock to a 52-week high. The positive momentum followed several key developments. Cantor Fitzgerald raised its price target on the stock to $40 from $35, keeping an Overweight rating, after the company's fourth-quarter fiscal 2025 results surpassed expectations. BofA Securities also increased its price target to $30.
Why SoundHound AI (SOUN) Shares Are Trading Lower Today
Shares of voice AI technology company SoundHound AI (NASDAQ:SOUN) fell 3.3% in the morning session after Piper Sandler lowered its price target on the shares, and a broader market sell-off added to the negative pressure.
Stocks making big moves yesterday: Compass, Intel, Fluence Energy, MarketAxess, and First Solar
Check out the companies making headlines yesterday:
Acuity Brands’s (NYSE:AYI) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) met Wall Streets revenue expectations in Q4 CY2025, with sales up 20.2% year on year to $1.14 billion. Its non-GAAP profit of $4.69 per share was 2.2% above analysts’ consensus estimates.
TD SYNNEX’s (NYSE:SNX) Q4 CY2025: Beats On Revenue
IT distribution giant TD SYNNEX (NYSE:SNX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.7% year on year to $17.38 billion. The company expects next quarter’s revenue to be around $15.5 billion, close to analysts’ estimates. Its non-GAAP profit of $3.83 per share was 2.7% above analysts’ consensus estimates.
Neogen (NASDAQ:NEOG) Beats Expectations in Strong Q4 CY2025, Stock Jumps 19.8%
Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue guidance of $850 million at the midpoint came in 3% above analysts’ estimates. Its non-GAAP profit of $0.10 per share was 50% above analysts’ consensus estimates.
Simply Good Foods (NASDAQ:SMPL) Beats Q4 CY2025 Sales Expectations
Packaged food company Simply Good Foods (NASDAQ:SMPL) reported revenue ahead of Wall Streets expectations in Q4 CY2025, but sales were flat year on year at $340.2 million. Its non-GAAP profit of $0.39 per share was 8.2% above analysts’ consensus estimates.
Lindsay (NYSE:LNN) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Agricultural and farm machinery company Lindsay (NYSE:LNN) fell short of the markets revenue expectations in Q4 CY2025, with sales falling 6.3% year on year to $155.8 million. Its GAAP profit of $1.54 per share was 4.4% above analysts’ consensus estimates.